Synergistic chemo-sirna combination therapy
Ended Cooperative Agreement Awarded Last action
- Award ID
- R01CA158300
- Recipient
-
Optimum Therapeutics, LLC UEI CAAGN783MMF1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,828,892
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $372,483 | |
| Amendment | $361,309 | |
| Amendment | $350,134 | |
| Amendment | $372,483 | |
| Original award | $372,483 |
Quick answers
Who received award R01CA158300?
R01CA158300 was awarded to Optimum Therapeutics, LLC by National Cancer Institute (National Institutes of Health) on September 26, 2011.
How much is award R01CA158300 worth?
$1,828,892 has been obligated on R01CA158300.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award